Oligonucleotide Synthesis Market Insights, 2019-2027

Oligonucleotide Synthesis Market (Product - Reagents & Consumables, Equipment, and Synthesized Oligonucleotides (DNA Oligonucleotides and RNA Oligonucleotides); Application - Research (Polymerase Chain Reaction and Next Generation Sequencing), Therapeutics (Antisense Oligonucleotides, and Nucleic Acid Aptamers), and Diagnostics; End User - Biotechnology & Pharmaceutical Companies, Research Institutes, and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global oligonucleotide synthesis market for the historical period 2017–2018 and forecast period 2019–2027, Increasing use of synthesized oligonucleotides in diagnostics and research applications, and Technological advancements in synthetic chemistry are projected to drive the global oligonucleotide synthesis market during the forecast period
  • According to the report, the global oligonucleotide synthesis market was valued at US$ 1,966.2 Mn in 2018 and is anticipated to expand at a CAGR of 9.5% from 2019 to 2027

To know the scope of our report Get a Sample on Oligonucleotide Synthesis Market

Technological advancements in synthetic chemistry to Drive Global Oligonucleotide Synthesis: Key Drivers

  • The advances in the technological development of organic molecules are expected to drive the growth of the oligonucleotide synthesis market
  • The advanced synthesis of oligonucleotides provides longer oligos with better sequence fidelity and higher purity that can be used in a number of molecular biology applications
  • Various pharmaceutical and biotechnology companies are continuously  working on developing newer and advanced methods in synthetic chemistry
  • For instance, Integrated DNA Technologies, leader of synthesized oligonucleotides has developed various pioneered methods to synthesize oligonucleotides of extreme lengths. The company has developed oligonucleotides up to 200 base length which is used with mass spectrometry for the manufacture of mini-genes.

Get a glimpse of the in-depth analysis through our Report Brochure

Increasing use of Synthesized Oligonucleotides in Diagnostics and Research Applications Boost Market Growth

  • Oligonucleotides have a wide range of applications in areas such as molecular biology, biotechnology, and diagnosis
  • Natural oligonucleotides have been extensively used for the selection and determination of DNA sequences (hybridization probes or affinity purification), gene construction, and site-directed mutagenesis
  • They constitute the basic reagents for PCR technologies. They are also used to selectively inhibit gene expression in in vitro studies for diagnostic purpose and more recently, their ability to interact with proteins has generated immense opportunity for therapeutic use.
  • Along with diagnostics, they are widely used in research studies. Combinatorial technology is another research area where oligonucleotides and their analogs are extensively employed.

Limitations in the Synthesis of Oligonucleotides to Hamper Market

  • An oligonucleotide is a single-stranded chain consisting of a number of nucleoside units linked together by phosphodiester bridges
  • Mostly in oligonucleotide synthesis, phosphodiesters are formed between a 3’-hydroxyl group bearing a phosphate derivative and a 5’-hydroxyl group of another nucleoside
  • The occurrence of side reactions sets practical limits for the length of synthetic DNA oligonucleotides (up to about 200 nucleotide residues) because the number of errors accumulates with the length of the oligonucleotide being synthesized
  • To synthesize RNA with longer nucleotides base, that is more than 50 nucleotides is very complex and difficult to prepare
  • But, most biologically important RNA molecules such as ribozymes, aptamers, and riboswitches are significantly longer than 50 nucleotides, so new approaches for the synthesis of RNA analogs are urgently required

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Oligonucleotide Synthesis Market: Competitive Landscape

  • This report profiles major players in the global oligonucleotide synthesis market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global oligonucleotide synthesis market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global Oligonucleotide Synthesis market are
    • GE Healthcare
    • Thermo Fischer Scientific
    • Agilent Technologies, Inc.
    • Merck KGaA
    • Integrated DNA Technologies, Inc.
    • Kaneka Eurogentec S.A
    • BioAutomation
    • Gene Design, Inc.
    • Eurofins Genomics
    • ATDBio, Ltd..

Global Oligonucleotide Synthesis Market: Key Developments

Key players in the global oligonucleotide synthesis market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global oligonucleotide synthesis market. A few expansion strategies adopted by players operating in the global oligonucleotide Synthesis market are:

  • In May 2017, GE Healthcare announced the launch of its Superdex 30 Increase, a new generation column resin for small-scale preparative purification and analysis, adding another product to the already existing wide portfolio of Superdex Increase family of SEC columns.

The report on the global oligonucleotide synthesis market discussed individual strategies, followed by company profiles of manufacturers of oligonucleotide synthesis. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global oligonucleotide synthesis market.

Global Oligonucleotide Synthesis Market – Segmentation

Product Product Type

  • Reagents & Consumables
  • Equipment
  • Synthesized Oligonucleotides
  • DNA
  • RNA
  • Others

Applications

  • Research
  • Polymerase Chain Reaction
  • Next Generation Sequencing
  • Others
  • Therapeutics
  • Antisense Oligonucleotides
  • Nucleic Acid Aptamers
  • Diagnostic

End User

  • Biotech & Pharma Companies
  • Research Inst.
  • Diagnostic Labs

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

What is the total market worth of oligonucleotide synthesis market?

Oligonucleotide synthesis market to reach US$ 4,511.3 Mn by 2027

What is the anticipated CAGR of the oligonucleotide synthesis market in the forecast period?

Oligonucleotide synthesis market is anticipated to expand at a CAGR of 9.5% from 2019 to 2027

What are the key driving factors for the growth of the oligonucleotide synthesis market?

Oligonucleotide synthesis market is driven by increasing use of synthesized oligonucleotides in diagnostics and research applications

What are the end-use segments in the oligonucleotide synthesis market?

The synthesized oligonucleotides segment dominated the global oligonucleotide synthesis market in 2018 and the trend is projected to continue during the forecast period

Who are the key players in the global oligonucleotide synthesis market?

Key players operating in the global Oligonucleotide Synthesis market are GE Healthcare, Thermo Fischer Scientific, Agilent Technologies, Inc., Merck KGaA, Integrated DNA, Technologies, Inc., Kaneka Eurogentec S.A

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Oligonucleotide Synthesis Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Oligonucleotide Synthesis Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Porter’s Five Force Analysis

        5.2. Value Chain Analysis

        5.3. Market Outlook

        5.4. Applications of Oligonucleotides

        5.5. PEST Analysis

        5.6. Pipeline Analysis 

    6. Global Oligonucleotide Synthesis Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Oligonucleotide Synthesis Market Value Forecast, by Product Type, 2017–2027

            6.2.1. Reagents & Consumables

            6.2.2. Equipment

            6.2.3. Synthesized oligonucleotides

                6.2.3.1. DNA Oligonucleotides  

                6.2.3.2. RNA Oligonucleotides 

                6.2.3.3. Others

        6.3. Global Oligonucleotide Synthesis Market Attractiveness, by Product Type

    7. Global Oligonucleotide Synthesis Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Oligonucleotide Synthesis Market Value Forecast, by Application, 2017–2027

            7.2.1. Research

                7.2.1.1. Polymerase Chain Reaction 

                7.2.1.2. Next Generation Sequencing 

                7.2.1.3. Others

            7.2.2. Therapeutics 

                7.2.2.1. Antisense Oligonucleotides

                7.2.2.2. Nucleic Acid Aptamers

            7.2.3. Diagnostics

        7.3. Global Oligonucleotide Synthesis Market Attractiveness, by Application

    8. Global Oligonucleotide Synthesis Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

            8.1.1. Key Findings / Developments

        8.2. Global Oligonucleotide Synthesis Market Value Forecast, by End-user, 2017–2027

            8.2.1. Biotechnology & Pharmaceutical Companies 

            8.2.2. Research Institutes  

            8.2.3. Diagnostic Laboratories

    9. Global Oligonucleotide Synthesis Market Attractiveness, by End-user

    10. Global Oligonucleotide Synthesis Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Global Oligonucleotide Synthesis Market Value Forecast, by Region

            10.2.1. North America 

            10.2.2. Europe 

            10.2.3. Asia Pacific 

            10.2.4. Latin America 

            10.2.5. Middle East & Africa 

        10.3. North America Oligonucleotide Synthesis Market Attractiveness, by Region

    11. North America Oligonucleotide Synthesis Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. North America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            11.2.1. Reagents & Consumables

            11.2.2. Equipment

            11.2.3. Synthesized oligonucleotides

                11.2.3.1. DNA Oligonucleotides  

                11.2.3.2. RNA Oligonucleotides 

                11.2.3.3. Others

        11.3. North America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027

            11.3.1. Research

                11.3.1.1. Polymerase Chain Reaction 

                11.3.1.2. Next Generation Sequencing 

                11.3.1.3. Others

            11.3.2. Therapeutics 

                11.3.2.1. Antisense Oligonucleotides

                11.3.2.2. Nucleic Acid Aptamers

            11.3.3. Diagnostics

        11.4. North America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            11.4.1. Biotechnology & Pharmaceutical Companies 

            11.4.2. Research Institutes  

            11.4.3. Diagnostic Laboratories

        11.5. North America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country, 2017–2027

            11.5.1. U.S.

            11.5.2. Canada

        11.6. North America Oligonucleotide Synthesis Market Attractiveness Analysis 

            11.6.1. By Product Type

            11.6.2. By Application

            11.6.3. By End-users

            11.6.4. By Country

    12. Europe Oligonucleotide Synthesis Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Europe Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            12.2.1. Reagents & Consumables

            12.2.2. Equipment

            12.2.3. Synthesized oligonucleotides

                12.2.3.1. DNA Oligonucleotides  

                12.2.3.2. RNA Oligonucleotides 

                12.2.3.3. Others

        12.3. Europe Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027

            12.3.1. Research

                12.3.1.1. Polymerase Chain Reaction 

                12.3.1.2. Next Generation Sequencing 

                12.3.1.3. Others

            12.3.2. Therapeutics 

                12.3.2.1. Antisense Oligonucleotides

                12.3.2.2. Nucleic Acid Aptamers

            12.3.3. Diagnostics

        12.4. Europe Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            12.4.1. Biotechnology & Pharmaceutical Companies 

            12.4.2. Research Institutes  

            12.4.3. Diagnostic Laboratories

        12.5. Europe Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.5.1. Germany

            12.5.2. U.K.

            12.5.3. France

            12.5.4. Spain

            12.5.5. Italy

            12.5.6. Rest of Europe 

        12.6. Europe Oligonucleotide Synthesis Market Attractiveness Analysis 

            12.6.1. By Product Type

            12.6.2. By Application

            12.6.3. By End-users

            12.6.4. By Country/Sub-region

    13. Asia Pacific Oligonucleotide Synthesis Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Asia Pacific Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            13.2.1. Reagents & Consumables

            13.2.2. Equipment

            13.2.3. Synthesized oligonucleotides

                13.2.3.1. DNA Oligonucleotides  

                13.2.3.2. RNA Oligonucleotides 

                13.2.3.3. Others

        13.3. Asia Pacific Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027

            13.3.1. Research

                13.3.1.1. Polymerase Chain Reaction 

                13.3.1.2. Next Generation Sequencing 

                13.3.1.3. Others

            13.3.2. Therapeutics 

                13.3.2.1. Antisense Oligonucleotides

                13.3.2.2. Nucleic Acid Aptamers

            13.3.3. Diagnostics

        13.4. Asia Pacific Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            13.4.1. Biotechnology & Pharmaceutical Companies 

            13.4.2. Research Institutes  

            13.4.3. Diagnostic Laboratories

        13.5. Asia Pacific Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.5.1. China

            13.5.2. Japan

            13.5.3. India

            13.5.4. Australia & New Zealand

            13.5.5. Rest of Asia Pacific 

        13.6. Asia Pacific Oligonucleotide Synthesis Market Attractiveness Analysis 

            13.6.1. By Product Type

            13.6.2. By Application

            13.6.3. By End-users

            13.6.4. By Country/Sub-region

    14. Latin America Oligonucleotide Synthesis Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Latin America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            14.2.1. Reagents & Consumables

            14.2.2. Equipment

            14.2.3. Synthesized oligonucleotides

                14.2.3.1. DNA Oligonucleotides  

                14.2.3.2. RNA Oligonucleotides 

                14.2.3.3. Others

        14.3. Latin America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027

            14.3.1. Research

                14.3.1.1. Polymerase Chain Reaction 

                14.3.1.2. Next Generation Sequencing 

                14.3.1.3. Others

            14.3.2. Therapeutics 

                14.3.2.1. Antisense Oligonucleotides

                14.3.2.2. Nucleic Acid Aptamers

            14.3.3. Diagnostics

        14.4. Latin America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            14.4.1. Biotechnology & Pharmaceutical Companies 

            14.4.2. Research Institutes  

            14.4.3. Diagnostic Laboratories

        14.5. Latin America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            14.5.1. Brazil

            14.5.2. Mexico

            14.5.3. Rest of Latin America Latin America 

        14.6. Latin America Oligonucleotide Synthesis Market Attractiveness Analysis 

            14.6.1. By Product Type

            14.6.2. By Application

            14.6.3. By End-users

            14.6.4. By Country/Sub-region

    15. Middle East & Africa Oligonucleotide Synthesis Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Middle East & Africa Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

            15.2.1. Reagents & Consumables

            15.2.2. Equipment

            15.2.3. Synthesized oligonucleotides

                15.2.3.1. DNA Oligonucleotides  

                15.2.3.2. RNA Oligonucleotides 

                15.2.3.3. Others

        15.3. Middle East & Africa Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027

            15.3.1. Research

                15.3.1.1. Polymerase Chain Reaction 

                15.3.1.2. Next Generation Sequencing 

                15.3.1.3. Others

            15.3.2. Therapeutics 

                15.3.2.1. Antisense Oligonucleotides

                15.3.2.2. Nucleic Acid Aptamers

            15.3.3. Diagnostics

        15.4. Middle East & Africa Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027

            15.4.1. Biotechnology & Pharmaceutical Companies 

            15.4.2. Research Institutes  

            15.4.3. Diagnostic Laboratories

        15.5. Middle East & Africa Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            15.5.1. GCC Countries

            15.5.2. South Africa

            15.5.3. Rest of Middle East & Africa 

        15.6. Middle East & Africa Oligonucleotide Synthesis Market Attractiveness Analysis 

            15.6.1. By Product Type

            15.6.2. By Application

            15.6.3. By End-users

            15.6.4. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (by Tier and Size of companies)

        16.2. Market Share / Position Analysis, by Company, 2018

        16.3. Competitive Business Strategies

        16.4. Company Profiles

            16.4.1. GE Healthcare

                16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.1.2. Financial Overview

                16.4.1.3. Product Portfolio

                16.4.1.4. SWOT Analysis

                16.4.1.5. Strategic Overview

            16.4.2. Thermo Fisher Scientific 

                16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.2.2. Financial Overview

                16.4.2.3. Product Portfolio

                16.4.2.4. SWOT Analysis

                16.4.2.5. Strategic Overview

            16.4.3. Agilent Technologies, Inc. 

                16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.3.2. Financial Overview

                16.4.3.3. Product Portfolio

                16.4.3.4. SWOT Analysis

                16.4.3.5. Strategic Overview

            16.4.4. Merck KGaA 

                16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.4.2. Financial Overview

                16.4.4.3. Product Portfolio

                16.4.4.4. SWOT Analysis

                16.4.4.5. Strategic Overview

            16.4.5. Integrated DNA Technologies, Inc.

                16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.5.2. Financial Overview

                16.4.5.3. Product Portfolio

                16.4.5.4. SWOT Analysis

                16.4.5.5. Strategic Overview

            16.4.6. Kaneka Eurogentec S.A. (Kaneka Corporation) 

                16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.6.2. Financial Overview

                16.4.6.3. Product Portfolio

                16.4.6.4. SWOT Analysis

                16.4.6.5. Strategic Overview 

            16.4.7. TriLink BioTechnologies,LLC  (Maravai Life Sciences) 

                16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.7.2. Financial Overview

                16.4.7.3. Product Portfolio

                16.4.7.4. SWOT Analysis

                16.4.7.5. Strategic Overview

            16.4.8. BioAutomation 

                16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.8.2. Financial Overview

                16.4.8.3. Product Portfolio

                16.4.8.4. SWOT Analysis

                16.4.8.5. Strategic Overview

            16.4.9. ATDBio Ltd.

                16.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.9.2. Financial Overview

                16.4.9.3. Product Portfolio

                16.4.9.4. SWOT Analysis

                16.4.9.5. Strategic Overview

            16.4.10. Gene Design, Inc. 

                16.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.10.2. Financial Overview

                16.4.10.3. Product Portfolio

                16.4.10.4. SWOT Analysis

                16.4.10.5. Strategic Overview

            16.4.11. Eurofins Genomics 

                16.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.4.11.2. Financial Overview

                16.4.11.3. Product Portfolio

                16.4.11.4. SWOT Analysis

                16.4.11.5. Strategic Overview

    List of Tables

    Table 1 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025

    Table 2 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025

    Table 3 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025

    Table 4 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025

    Table 5 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025

    Table 6 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025

    Table 7 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Region, 2015–2025

    Table 8 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025

    Table 9 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025

    Table 10 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025

    Table 11 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025

    Table 12 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025

    Table 13 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025

    Table 14 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025

    Table 15 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025

    Table 16 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025

    Table 17 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025

    Table 18 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025

    Table 19 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025

    Table 20 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025

    Table 21 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025

    Table 22 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025

    Table 23 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025

    Table 24 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025

    Table 25 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025

    Table 26 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025

    Table 27 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025

    Table 28 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025

    Table 29 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025

    Table 30 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025

    Table 31 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025

    Table 32 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025

    Table 33 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025

    Table 34 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025

    Table 35 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025

    Table 36 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025

    Table 37 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025

    Table 38 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025

    Table 39 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025

    Table 40 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025

    Table 41 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025

    Table 42 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025

    List of Figures

    Figure 1 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, 2017–2027

    Figure 2 Global oligonucleotide Synthesis Market Value Share, by Product Type (2018)

    Figure 3 Global oligonucleotide Synthesis Market Value Share, by Application (2018)

    Figure 4 Global oligonucleotide Synthesis Market Value Share, by End User (2018)

    Figure 5 Global oligonucleotide Synthesis Market Value Share, by Region (2018)

    Figure 6 Global Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025

    Figure 7 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents & Consumables, 2017–2027

    Figure 8 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equipment, 2017–2027

    Figure 9 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthesized Oligonucleotides, 2017–2027

    Figure 10 Global Oligonucleotide Synthesis Market Attractiveness, by Product Type

    Figure 11 Global Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025

    Figure 12 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research, 2017–2027

    Figure 13 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2017–2027

    Figure 14 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2017–2027

    Figure 15 Global Oligonucleotide Synthesis Market Attractiveness, by Application 

    Figure 16 Global Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025

    Figure 17 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2017–2027

    Figure 18 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research Institutes, 2017–2027

    Figure 19 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027

    Figure 20 Global Oligonucleotide Synthesis Market Attractiveness, by End-user 

    Figure 21 Global Oligonucleotide Synthesis Market Value Share, by Region, 2017 and 2025 

    Figure 22 Global Oligonucleotide Synthesis Market Attractiveness, by Region, 2019–2027

    Figure 23 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 24 North America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025

    Figure 25 North America Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027

    Figure 26 North America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025

    Figure 27 North America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027

    Figure 28 North America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025

    Figure 29 North America Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027

    Figure 30 North America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025

    Figure 31 North America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027

    Figure 32 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 33 Europe Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025

    Figure 34 Europe Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027

    Figure 35 Europe Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025

    Figure 36 Europe Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027

    Figure 37 Europe Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025

    Figure 38 Europe Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027

    Figure 39 Europe Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025

    Figure 40 Europe Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027

    Figure 41 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 42 Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025

    Figure 43 Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027

    Figure 44 Asia Pacific Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025

    Figure 45 Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027

    Figure 46 Asia Pacific Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025

    Figure 47 Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027

    Figure 48 Asia Pacific Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025

    Figure 49 Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027

    Figure 50 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 51 Latin America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025

    Figure 52 Latin America Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027

    Figure 53 Latin America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025

    Figure 54 Latin America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027

    Figure 55 Latin America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025

    Figure 56 Latin America Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027

    Figure 57 Latin America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025

    Figure 58 Latin America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027

    Figure 59 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027

    Figure 60 Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025

    Figure 61 Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027

    Figure 62 Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025

    Figure 63 Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027

    Figure 64 Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025

    Figure 65 Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027

    Figure 66 Middle East & Africa Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025

    Figure 67 Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027

    Figure 68 Global Oligonucleotide Synthesis Market Share, by Company, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved